A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
for PAH
48 locations incl. Phoenix
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT03683186·Phase 3·Enrolling By Invitation·Listed Sep 2018